Similar articles

• Introduction: Do we need multi-stakeholder colloquia in MS?

  Vermersch P, Smets L, Gold R. Vermersch P, et al. Mult Scler. 2016 Aug;22(2 Suppl):4-8. doi: 10.1177/1352458516650740. Mult Scler. 2016. PMID: 27465611
• The patient's perspective: How to create awareness for improving access to care and treatment of MS patients?

  Vermersch P, Faller A, Czarnota-Szałkowska D, Meesen B, Thalheim C. Vermersch P, et al. Mult Scler. 2016 Aug;22(2 Suppl):9-17. doi: 10.1177/1352458516650742. Mult Scler. 2016. PMID: 27465612
• The importance of a multi-disciplinary perspective and patient activation programmes in MS management.

  Feys P, Giovannoni G, Dijsselbloem N, Centonze D, Eelen P, Lykke Andersen S. Feys P, et al. Mult Scler. 2016 Aug;22(2 Suppl):34-46. doi: 10.1177/1352458516650741. Mult Scler. 2016. PMID: 27465614 Review.
• Conclusions: Calls to action for improving the life of MS patients and their families.

  Vermersch P, Smets L, Gold R. Vermersch P, et al. Mult Scler. 2016 Aug;22(2 Suppl):71-7. doi: 10.1177/1352458516650738. Mult Scler. 2016. PMID: 27465617
• The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?

  Gold R, Toumi M, Meesen B, Fogarty E. Gold R, et al. Mult Scler. 2016 Aug;22(2 Suppl):60-70. doi: 10.1177/1352458516650743. Mult Scler. 2016. PMID: 27465616 Review.